<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Information Statement Pursuant to Rules 13d-1 and 13d-2
Under the Securities Exchange Act of 1934
(Amendment No. )*
------
Aviron
----------------------------------
(Name of Issuer)
Common
----------------------------------
(Title of Class of Securities)
053762 10 0
----------------------------------
(CUSIP Number)
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter the disclosures provided in a prior page.
The information required in the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
(Continued on following page(s))
Page 1 of 5 Pages
---
<PAGE>
CUSIP No. 053762 10 0 13G Page 2 of 5 Pages
----------- --- ---
- -------------------------------------------------------------------------------
(1) Names of Reporting Persons. S.S. or I.R.S. Identification Nos. of Above
Persons
Sang-A Pharm. Co., Ltd.
- -------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member (a) / /
of a Group* (b) / /
- -------------------------------------------------------------------------------
(3) SEC Use Only
- -------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
South Korea
- -------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
Beneficially 1,092,296
Owned by --------------------------------------------------
Each Reporting (6) Shared Voting Power
Person With
--------------------------------------------------
(7) Sole Dispositive Power
1,092,296
--------------------------------------------------
(8) Shared Dispositive Power
- -------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
1,092,296
- -------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
- -------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
9.5%
- -------------------------------------------------------------------------------
(12) Type of Reporting Person*
OO
- -------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP No. 053762 10 0 13G Page 3 of 5 Pages
----------- --- ---
ITEM 1(A). NAME OF ISSUER
Aviron
- -------------------------------------------------------------------------------
ITEM 1(B). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
297 North Bernardo Avenue
Mountain View, CA 94043
- -------------------------------------------------------------------------------
ITEM 2(A). NAME OF PERSON(S) FILING
Sang-A Pharm. Co., Ltd.
- -------------------------------------------------------------------------------
ITEM 2(B). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE
640-9 Deung Chon Dung, Kangsea-Ku Seoul, South Korea
- -------------------------------------------------------------------------------
ITEM 2(C). CITIZENSHIP
South Korea
- -------------------------------------------------------------------------------
ITEM 2(D). TITLE OF CLASS OF SECURITIES
Common Stock
- -------------------------------------------------------------------------------
ITEM 2(E). CUSIP NUMBER
053762 10 0
- -------------------------------------------------------------------------------
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR 13d-2(b),
CHECK WHETHER THE PERSON FILING IS A:
Not Applicable
- -------------------------------------------------------------------------------
<PAGE>
Page 4 of 5 Pages
--- ---
ITEM 4. OWNERSHIP
(a) Amount Beneficially Owned:
1,092,296
---------------------------------------------------------------------------
(b) Percent of Class:
9.5%
---------------------------------------------------------------------------
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote
1,092,296
-----------------------------------------------------------------
(ii) shared power to vote or to direct the vote
0
-----------------------------------------------------------------
(iii) sole power to dispose or to direct the disposition of
1,092,296
-----------------------------------------------------------------
(iv) shared power to dispose or to direct the disposition of
0
-----------------------------------------------------------------
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not Applicable
- -------------------------------------------------------------------------------
ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
Not Applicable
- -------------------------------------------------------------------------------
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY
Not Applicable
- -------------------------------------------------------------------------------
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
Not Applicable
- -------------------------------------------------------------------------------
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not Applicable
- -------------------------------------------------------------------------------
ITEM 10. CERTIFICATION
Not Applicable
- -------------------------------------------------------------------------------
<PAGE>
Page 5 of 5 Pages
--- ---
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and
correct.
February 11, 1997
----------------------------------------
(Date)
/s/ Karen Herlihy
----------------------------------------
(Signature)
Karen Herlihy/Attorney-In-Fact
----------------------------------------
(Name/Title)
